A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Zeno Pharmaceuticals, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT03446417
- Locations
- 🇺🇸
Site 2, Duarte, California, United States
🇺🇸Site 5, Detroit, Michigan, United States
🇺🇸Site 1, East Setauket, New York, United States